Unavailable
Unavailable
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 7/14/2025 | Mkt Outperform → Mkt Perform | Citizens JMP | |
| 7/9/2025 | $142.00 | Buy → Hold | HSBC Securities |
| 6/30/2025 | $150.00 | Overweight | Piper Sandler |
| 5/14/2025 | $150.00 | Equal-Weight → Overweight | Morgan Stanley |
| 4/15/2025 | $119.00 | Hold → Buy | HSBC Securities |
| 3/20/2025 | $150.00 → $141.00 | Equal Weight → Overweight | Wells Fargo |
| 1/30/2025 | $173.00 | Buy → Hold | HSBC Securities |
| 9/18/2024 | $148.00 | Buy | HSBC Securities |
4 - KKR & Co. Inc. (0001404912) (Issuer)
4 - KKR & Co. Inc. (0001404912) (Issuer)
4 - KKR & Co. Inc. (0001404912) (Reporting)
10-Q - KKR & Co. Inc. (0001404912) (Filer)
144 - KKR & Co. Inc. (0001404912) (Subject)
8-K - KKR & Co. Inc. (0001404912) (Filer)
Strategic Partnership to Advance Site Network Expansion and Accelerate Clinical Trial Innovation THL Partners ("THL"), a premier private equity firm investing in middle market growth companies, today announced the entry into a definitive agreement to acquire Headlands Research ("Headlands" or "the Company"), a leading multinational network of clinical trial sites, from funds managed by leading global investment firm KKR. The strategic partnership between THL and Headlands will fuel Headlands' continued expansion, enhance its technology and centralized infrastructure, and further strengthen its ability to deliver high-quality, diverse clinical trial data for pharmaceutical and biotech spon
KKR, a leading global investment firm, today announced that credit funds and accounts managed by KKR served as lead investors on a financing to support the growth investment from funds managed by Harvest Partners, LP ("Harvest") in Med-Metrix, LLC ("Med-Metrix" or "the Company"), a leading provider of technology-enabled Revenue Cycle Management ("RCM") solutions. KKR Capital Markets also served as Left Lead Arranger and Bookrunner on the transaction. The Company's management team, led by CEO Joseph Davi, will continue to lead Med-Metrix and remain significant owners of the business. Med-Metrix's prior owner, A&M Capital ("AMC"), will retain a minority stake in the Company and invest addit
Declares Third Quarter 2025 Distribution of $0.70 per share PHILADELPHIA and NEW YORK, Aug. 6, 2025 /PRNewswire/ -- FS KKR Capital Corp. (NYSE:FSK), or the Company, today announced its financial and operating results for the quarter ended June 30, 2025, and that its board of directors has declared a third quarter 2025 distribution of $0.70 per share. Financial and Operating Highlights for the Quarter Ended June 30, 2025(1) Net investment income of $0.62 per share, compared to $0.67 per share for the quarter ended March 31, 2025Adjusted net investment income(2) of $0.60 per sha
Citizens JMP downgraded KKR from Mkt Outperform to Mkt Perform
HSBC Securities downgraded KKR from Buy to Hold and set a new price target of $142.00
Piper Sandler initiated coverage of KKR with a rating of Overweight and set a new price target of $150.00
4 - KKR & Co. Inc. (0001404912) (Issuer)
4 - KKR & Co. Inc. (0001404912) (Reporting)
4 - KKR & Co. Inc. (0001404912) (Issuer)
Unlocks ~$1.25 billion of discretionary cash for Harley-Davidson and transforms Harley-Davidson Financial Services (HDFS) into a capital-light and derisked business that will continue to originate and service both new and existing retail loans Transaction monetizes HDFS through sale of 4.9% common equity interests to each partner and includes the sale of more than $5 billion of retail loan receivables at a premium to par HDFS has agreed to sell approximately two-thirds of retail loans originated by HDFS annually for a minimum period of five years Values HDFS at ~1.75x price to post-transaction book value and reinforces strategic and financial value of HDFS to Harley-Davidson customers, dea
Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today announced the successful completion of a $250 million strategic investment by funds affiliated with KKR, a leading global investment firm. Upon the closing of this transaction, KKR has become the holder of approximately 12% of the common shares of Henry Schein. In connection with the investment, William K. "Dan" Daniel, Executive Advisor to KKR and former Executive Vice President of Danaher Corporation, has officially joined Henry Schein's Board of Directors as an independent director. He joins Max Lin, Partner at KKR and leader of the firm's Healt
KKR & Co. Inc. (NYSE:KKR) today announced that Timothy R. Barakett has been appointed to the Board of Directors effective March 13, 2025. His appointment will bring the number of independent directors to ten out of a total of fourteen Board seats. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250313966947/en/Timothy R. Barakett (Photo: Business Wire) Mr. Barakett is the Founder and Chief Executive Officer of TRB Advisors, a private investment firm and family office. Prior to founding TRB Advisors in 2010, Mr. Barakett was the Founder and Chief Executive Officer of Atticus Capital, a global investment management firm. Mr. Baraket
Declares Third Quarter 2025 Distribution of $0.70 per share PHILADELPHIA and NEW YORK, Aug. 6, 2025 /PRNewswire/ -- FS KKR Capital Corp. (NYSE:FSK), or the Company, today announced its financial and operating results for the quarter ended June 30, 2025, and that its board of directors has declared a third quarter 2025 distribution of $0.70 per share. Financial and Operating Highlights for the Quarter Ended June 30, 2025(1) Net investment income of $0.62 per share, compared to $0.67 per share for the quarter ended March 31, 2025Adjusted net investment income(2) of $0.60 per sha
KKR & Co. Inc. (NYSE:KKR) today reported its second quarter 2025 results, which have been posted to the Investor Center section of KKR's website at https://ir.kkr.com/events-presentations/. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250731323085/en/ A conference call to discuss KKR's financial results will be held today, Thursday, July 31, 2025 at 9:00 a.m. ET. The conference call may be accessed by dialing (877) 407-0312 (U.S. callers) or +1 (201) 389-0899 (non-U.S. callers); a pass code is not required. Additionally, the conference call will be broadcast live over the Internet and may be accessed through the Investor Cente
KKR & Co. Inc. (NYSE:KKR) announced today that it plans to release its financial results for the second quarter 2025 on Thursday, July 31, 2025, before the opening of trading on the New York Stock Exchange. A conference call to discuss KKR's financial results will be held on Thursday, July 31, 2025 at 9:00 a.m. ET. The conference call may be accessed by dialing (877) 407-0312 (U.S. callers) or +1 (201) 389-0899 (non-U.S. callers); a pass code is not required. Additionally, the conference call will be broadcast live over the Internet and may be accessed through the Investor Center section of KKR's website at https://ir.kkr.com/events-presentations/. A replay of the live broadcast will be a
SC 13G/A - KKR & Co. Inc. (0001404912) (Subject)
SC 13G/A - KKR & Co. Inc. (0001404912) (Subject)
SC 13G/A - KKR & Co. Inc. (0001404912) (Subject)